NSC 115.93 Norfolk Southern Corp $NSC Hit a 52 week high of

New Post Public Reply Private Reply Replies (0) Message Board
DennyT
NSC 115.93 Norfolk Southern Corp $NSC Hit a 52 week high of 116.69 Currently at 115.93 -0.67 -0.57% With a day low of 115.72 and a total volume of 120,779.

NSC Norfolk Southern Corp Recent Headline News

Early Glance: Railroad companies
AP - 2 hrs 30 mins ago
NEW YORK (AP) — Shares of some top railroad companies are mixed at 10 a.m.:
CP.TO: 237.51 (+0.01), NSC: 115.80 (-0.80), CNI: 70.79 (+0.34), CP: 209.46 (+0.53), CNR.TO: 80.26 (+0.07)

Railroads Grow Faster Than The Economy
Michael Hooper - at Seeking Alpha - Tue Nov 11, 6:07AM CST

NSC: 115.80 (-0.80), SPY: 203.77 (-0.21), CNI: 70.79 (+0.34), KSU: 125.27 (+0.52), CP: 209.46 (+0.53), IYT: 161.77 (-0.70), CSX: 36.51 (-0.05), BRK.B: 144.97 (-0.08), UNP: 120.86 (-0.04)

Final Glance: Railroad companies
AP - Mon Nov 10, 5:07PM CST
NEW YORK (AP) — Shares of some top railroad companies were up at the close of trading:
CP.TO: 237.51 (+0.01), NSC: 115.80 (-0.80), CNI: 70.79 (+0.34), CP: 209.46 (+0.53), CNR.TO: 80.26 (+0.07)

Alibaba's Massive Revenue on China's 'Singles Day;' Are Target, GoPro Buys?
at The Street - Mon Nov 10, 3:05PM CST
CNBC's 'Fast Money' trading panel believe shares of Alibaba will have momentum going into 2015, while U.S. consumers will continue to benefit from lower gas prices.
BID: 41.51 (+0.06), GPRO: 74.39 (-1.36), NSC: 115.80 (-0.80), KWEB: 37.42 (-0.39), DDD: 34.50 (-1.72), TLT: 118.52 (-0.13), SPY: 203.77 (-0.21), QQQ: 101.90 (-0.06), TGT: 65.53 (+0.01), DIA: 175.84 (-0.11), MCD: 95.17 (+0.06), DF: 16.24 (-0.16), IWM: 116.99 (-0.30), BABA: 115.30 (-3.85)

Midday Glance: Railroad companies
AP - Mon Nov 10, 12:28PM CST
NEW YORK (AP) — Shares of some top railroad companies are up at 1 p.m.:
CP.TO: 237.51 (+0.01), NSC: 115.80 (-0.80), CNI: 70.79 (+0.34), CP: 209.46 (+0.53), CNR.TO: 80.26 (+0.07)

Earnings Flashback: Since Reporting Quarterly Results 2 Weeks Ago Norfolk Southern Is Up 6.0% (NSC)
Comtex SmarTrend(R) - Mon Nov 10, 8:26AM CST
Two weeks ago on October 22nd, 2014 Norfolk Southern (NYSE:NSC) reported earnings and analysts, on average, expected earnings of $1.83 on sales of $3.1 billion. Norfolk Southern actually reported earnings of $1.79 per share on sales of $3.0 billion, missing EPS estimates by $0.04 and missing revenue estimates by $46.3 million. Since the company's report, shares of Norfolk Southern have risen from $106.50 to $112.86, representing a gain of 6.0% in the past 19 days.
NSC: 115.80 (-0.80)

Axion Power's IPO Crash: An Opportunity To Buy?
Retired Aviator - at Seeking Alpha - Sat Nov 08, 11:56AM CST

NSC: 115.80 (-0.80), AXPW: 1.78 (+0.03)

After Yesterday's Rally of 1.93% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Fri Nov 07, 3:53PM CST
Norfolk Southern (NYSE:NSC) traded in a range yesterday that spanned from a low of $111.93 to a high of $114.40. Yesterday, the shares gained 1.9%, which took the trading range above the 3-day high of $111.15 on volume of 2.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
NSC: 115.80 (-0.80)

October Railroad Report: Keep Rolling On
Investor RockieK - at Seeking Alpha - Fri Nov 07, 10:00AM CST

NSC: 115.80 (-0.80), CNI: 70.79 (+0.34), KSU: 125.27 (+0.52), CP: 209.46 (+0.53), CSX: 36.51 (-0.05), BRK.A: 217,394.20 (-105.80), UNP: 120.86 (-0.04)

Norfolk Southern +3.5% as Ackman says CP Rail may buy competitor to CSX
Seeking Alpha - at Seeking Alpha - Fri Nov 07, 7:46AM CST

NSC: 115.80 (-0.80), CP: 209.46 (+0.53)

Dividend Contenders, Future Champions Or Future Failures: Part 5
Stan Stafford - at Seeking Alpha - Wed Nov 05, 7:30PM CST

NSC: 115.80 (-0.80), CNI: 70.79 (+0.34), CSX: 36.51 (-0.05)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 337

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Community in Shock After Fatal Bakersfield Shooting

Updated Category News Views 130

The Ripple Effect of Tragedy Grief has a way of shaking a community down to its core—especially when the loss emanates from such senseless violence as the shooting death of 17-year-old Levi Brown. This wasn't just a tragic occurrence at a Friday night football game in Bakersfield; it was a visceral crack in the perceived safety of community events. Levi's Legacy and...

Continue Reading
Vantrue's Black Friday Dash Cam Deals: Save up to 44%

Updated Category News Views 148

Kicking Off Early Black Friday with Dash Cam Bargains In a bid to stay ahead of the holiday shopping rush, Vantrue announced its early Black Friday campaign with a range of discounts designed to capture the interest of road warriors and casual drivers alike. From November 1 to November 21, 2026, Vantrue is inviting bargain hunters to explore their offerings—culminating...

Continue Reading
Firefox Champions Privacy with Iconic Internet Campaign

Updated Category News Views 121

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 249

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 197

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Sinclair Faces Labor Lawsuit for Break-time Violations

Updated Category News Views 199

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Continue Reading
Ping An's Bold Green Moves Ahead of APEC 2026

Updated Category News Views 201

Ping An's Pitch for Green: Talking the Talk and Walking the Walk? Well, here's something cooking in Shenzhen at the Ping An Finance Center—an international seminar championing green development initiatives. It's all buzz around Ping An Insurance (HKEX: 2318; SSE: 601318) flexing its green muscle, orchestrating conversations right before APEC 2026. Talk about timing....

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 186

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
Monster Energy Unleashes Gaming Frenzy at Cosm L.A. Event

Updated Category News Views 152

Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...

Continue Reading

Top 5 Most Recently Viewed Articles

Mobility Direct's Inspiring Journey in Supporting the Disabled

Updated Category News Views 123

Empowering Mobility for a Decade Mobility Direct has reached a remarkable milestone, celebrating ten years of dedicated service to individuals facing mobility challenges. The company, based in Florida, has profoundly impacted the lives of many by providing free mobility scooters to those in need. With each scooter given, they challenge the common assumption that mobility...

Continue Reading
GARDANT GLOBAL Teams Up with GovConRx for Enhanced Services

Updated Category News Views 143

GARDANT GLOBAL Forms Strategic Alliance with GovConRx GARDANT GLOBAL is thrilled to share exciting news about its latest partnership with GovConRx. This collaboration is set to transform the landscape of contract performance management for government contractors. GovConRx, well-known for its expertise in enhancing CPARS ratings, will significantly augment GARDANT's...

Continue Reading
Text Request and Commify Join Forces to Enhance Messaging Solutions

Updated Category News Views 72

Text Request and Commify Join Forces to Enhance Messaging Solutions Text Request, a leader in the business text messaging domain, has recently announced an exciting new chapter following its acquisition by the U.K.-based Commify. This strategic move is aimed at expanding its reach within the U.S. market while maintaining its operational base in Chattanooga. Growth Journey...

Continue Reading
Agenus Investors Alerted on Class Action Lawsuit Developments

Updated Category News Views 64

Levi & Korsinsky Notifies Investors of Class Action for Agenus Inc. Levi & Korsinsky, LLP is reaching out to investors in Agenus Inc. (NASDAQ: AGEN) regarding a significant class action lawsuit that may impact those financially affected by the company's alleged misrepresentations. This development is crucial for stakeholders who have invested in Agenus during the...

Continue Reading
Savvas Unveils Innovative Science Curriculum for Students

Updated Category News Views 369

Introducing Experience Science for Grades K-8 In a groundbreaking initiative, Savvas Learning Company has launched Experience Science, an all-new program curated specifically for students in grades K-8. This innovative curriculum aims to engage young learners in scientific concepts, placing significant emphasis on hands-on experiences driven by real-world phenomena....

Continue Reading